阿斯利康公布成绩单。2月6日,阿斯利康公布了全年财报业绩。数据显示,2024年,阿斯利康业绩表现亮眼,总营收实现21%增长,达到541亿美元。阿斯利康中国业务继续保持强劲增长,总营收实现11%双位数增长,达到64亿美元,占全球收入12%。信达生物展示肌肉。2月6日,信达生物公告表示,2024年收入超82亿,同比增长超40%。第四季度,公司收入超20亿元。复宏汉霖持续收获出海成果。2月5日,复宏汉霖...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.